Search results
NICE's methodology means people with cancer aren't getting drugs - AstraZeneca's Sir Pascal Soriot...
Sky News via Yahoo Canada News· 5 days agoThe chief executive of AstraZeneca has criticised a public health body for refusing to make one of...
AstraZeneca, Roche Intensify New Drug Push, Automakers Sink Post-Earnings | The Opening Trade 07/25
Bloomberg· 5 days agoWith analysis you won't find anywhere else, we break down the biggest stories of the day and speak...
Business Brief: The price we pay for borrowing and bread
The Globe and Mail· 5 days agoA scoop to start: Canada’s largest grocer, Loblaw Cos. Ltd., and its parent company George Weston...
AstraZeneca raises profit outlook on strong medicines demand
The Globe and Mail· 5 days agoAnglo-Swedish drugmaker AstraZeneca AZN-Q raised its full year sales and profit forecast on Thursday...
AstraZeneca Lifts Guidance as Demand for Cancer Drugs Grows
Bloomberg· 5 days agoAstrazeneca Chief Financial Officer Aradhana Sarin discusses earnings results as the company raised...
Britain’s Access to New Drugs Could ‘Totally Shrink,’ Says Astra Chief
Bloomberg· 5 days agoAstraZeneca Plc Chief Executive Officer Pascal Soriot has a warning for Britain’s new Labour...
Astrazeneca: Q2 Earnings Snapshot
Associated Press Finance via Yahoo Finance Canada· 5 days agoCAMBRIDGE, Britain (AP) — CAMBRIDGE, Britain (AP) — Astrazeneca PLC (AZN) on Thursday reported second-quarter net income of $1.93 billion. On a per-share basis, the Cambridge ...
They’ve Got Next: The 40 Under 40—Where Are They Now?
Bloomberg Law· 5 days agoSince we launched the Bloomberg Law “They’ve Got Next: The 40 Under 40” in 2021, some of our honorees have made big career moves, whether that meant leaving their firms for new roles in government ...
Europe’s Biggest Drugmakers Raise Guidance on New Product Demand
Bloomberg· 5 days agoBig European drugmakers lifted their financial guidance as a focus on new, innovative drugs helped...
AstraZeneca shares fall despite guidance raise as drugmaker warns on income
Investing.com via Yahoo Finance Canada· 5 days agoInvesting.com – Shares of AstraZeneca (NASDAQ:AZN) (LON:AZN) dropped on Thursday after the company reported that other operating income is expected to "decrease substantially ...
